Real investment cost used in the process of research and development of major domestic new drugs increased as the same level of advanced countries

According to the analysis of real investment cost used in the process of research and development of major domestic new drugs, 297.7 billion won was invested in the development process of the country's first global new drug "Factive (new quinolone antibiotics)" for 13 years.

18 billion won was invested in the development process of Dong Pharmaceutical's "Stillen capsule" (gastritis treatment) ...